8 Results

People

  1. Chung
    Chung
  2. Dahi
    Dahi
  3. Giralt
    Giralt
  4. Lahoud
    Lahoud
  5. Landau
    Landau
  6. Scordo
    Scordo
  7. Shah
    Shah
  8. Devlin
    Devlin
  9. Scheinberg
    Scheinberg
  10. Dao
    Dao

Groups

  1. Department of Medicine (8)
  2. Hematologic Malignancies, Division of (8)
  3. MSK Grad Students (8)
  4. Center for Hematologic Malignancies (7)
  5. CTCR Scholars (5)
  6. Hematologic Malignancies Research (5)
  7. Master of Science in Clinical and Translational Cancer Research (5)
  8. Bone Marrow Transplant (4)
  9. Sloan Kettering Institute Postdocs (4)
  10. Survivorship Research (4)
  1. "Department of Medicine"
  2. "MSK Grad Students"
  3. "Clinical Lymphoma, Myeloma and Leukemia"
Formats
  1. Meeting Abstract (8)
Groups
  1. Department of Medicine (8)
  2. Hematologic Malignancies, Division of (8)
  3. MSK Grad Students (8)
  4. Center for Hematologic Malignancies (7)
  5. CTCR Scholars (5)
  6. Hematologic Malignancies Research (5)

More Groups

People
  1. David Chung (4)
  2. Gunjan Shah (4)
  3. Heather Landau (4)
  4. Michael Scordo (4)
  5. Oscar Lahoud (4)
  6. Parastoo Dahi (4)

More People

Years
  1. 2023 (1)
  2. 2021 (2)
  3. 2019 (3)
  4. 2018 (1)
  5. 2016 (1)
Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (8)
Publishers
  1. Elsevier Inc. (8)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Successful incorporation of ePRO using PROMIS-29 into standard of care after hematopoietic stem cell transplant and chimeric antigen receptor T cell therapy for plasma cell dyscrasias
    Meeting Abstract

    Shah, G.; Lobaugh, S.; Devlin, S.; Atkinson, T.; Korde, N.; Chung, D.; Dahi, P.; Landau, H.; Lahoud, O.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • A tumor-agnostic TCR-mimic CAR-T cell specific for NDC80 targets multiple hematological malignancies
    Meeting Abstract

    Klatt, M. G.; Dao, T.; Yang, Z.; Liu, J.; Mun, S. S.; Dacek, M. M.; Luo, H.; Gardner, T. J.; Bourne, C.; Peraro, L.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Five-year overall survival from the CheckMate 205 study of nivolumab for relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL)
    Meeting Abstract

    Ansell, S.; Bröckelmann, P.; von Keudell, G.; Lee, H. J.; Santoro, A.; Zinzani, P. L.; Collins, G.; Cohen, J.; De Boer, J. P.; Kuruvilla, J.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Interleukin-6 (IL-6) blockade with siltuximab peri-autologous hematopoietic stem cell transplantation (AHCT) may reduce symptom burden by altering the cytokine milieu in older patients with multiple myeloma (MM)
    Meeting Abstract

    Shah, G.; Holder, J.; Cho, S.; Murata, K.; Devlin, S.; Hoover, E.; Chung, D.; Dahi, P.; Lahoud, O.; Scordo, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Successful pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G.; Lin, A.; Grumley, A.; Kamrowski, A.; Schofield, R.; Devlin, S.; Bhatt, V.; Proli, A.; Chung, D.; Dahi, P.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Stem cell mobilization and autograft purity with novel induction regimens in multiple myeloma
    Meeting Abstract

    Bal, S.; Landau, H.; Shah, G.; Scordo, M.; Dahi, P.; Lahoud, O.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lesokhin, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Improved sensitivity and specificity for mutated and unmutated class I HLA ligand identifications lead to better immunotherapy target discovery
    Meeting Abstract

    Klatt, M.; Gejman, R.; Mun, S. S.; Dao, T.; Scheinberg, D.
    Clinical Lymphoma, Myeloma and Leukemia (2018)

    Fulltext@MSK | Save
  • CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra-low density cancer epitopes
    Meeting Abstract

    Mathias, M.; Sockolosky, J.; Chang, A.; Liu, C.; Garcia, K.; Scheinberg, D.
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save